GL1X · GenesisL1 explorer

MolNFT v1 · #118308 · protein

Crystal structure of cody from staphylococcus aureus with GTP and ile

5EY0 · GTP-sensing transcriptional pleiotropic repressor cody: “Crystal structure of cody from staphylococcus aureus with GTP and ile”. X-ray diffraction, 2 ligands (ILE, GTP), 8 pockets (best druggability 0.56). MolNFT v1 #118308 on…

PDB
5EY0
Type
protein
Length
505 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTP-sensing transcriptional pleiotropic repressor cody
UniProt
A7X1N2
Ligands
ILE, GTP
Pockets
8 · best druggability 0.56

Structure

x-ray diffraction · 2 distinct chains · 52% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BGTP-sensing transcriptional pleiotropic repressor codyprotein25354% helix, 19% strandA7X1N2
AGTP-sensing transcriptional pleiotropic repressor codyprotein25251% helix, 19% strandA7X1N2

Ligands and binding sites

  • ILE · Isoleucine · ligand · 2 copies · chains B, A
  • GTP · Guanosine-5'-triphosphate · ligand · 2 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13090.560.7640empty
2830.490.8318ILE
3830.470.8115ILE
4650.380.7914empty
5800.360.7613empty

Interfaces

1 interface between chains.

  • B–A · 1684 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 5EY0 · Crystal structure of CodY from Staphylococcus aureus with GTP and Ile · the same entry in another collection · chain A against A, TM-score 1.00
  • A7X1N2 · AlphaFold monomer V2.0 prediction for GTP-sensing transcriptional pleiotropic repressor… · a predicted model of the same protein · chain B against A, TM-score 0.86

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.